AnaptysBio Inc (ANAB)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 6.81M | 1.37M | 3.46M | 3.32M | 9.01M | 7.18M | 10.97M | 30.02M |
営業利益 | -25.97M | -44.4M | -40.14M | -37.73M | -42.14M | -42.2M | -40.32M | -22.76M |
税引前収入 | -26.39M | -44.26M | -39.85M | -37.31M | -42.22M | -43.94M | -46.65M | -32.85M |
純利益 | -26.41M | -44.26M | -39.85M | -37.31M | -42.21M | -43.94M | -46.66M | -32.85M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -25.98M | -44.41M | -40.14M | -37.73M | -42.14M | -42.2M | -40.32M | -22.76M |
EBITDA | -25.79M | -44.24M | -39.98M | -37.57M | -41.97M | -42.04M | -40.17M | -22.61M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 16.68M | 10M | 5M | 8M | 75M | 63.18M | 10.29M | 17.16M |
営業利益 | -3.03M | -28.78M | -66.72M | -107.43M | -23.88M | -56.81M | -115.15M | -164.41M |
税引前収入 | -4.26M | -30.07M | -61.85M | -97.49M | -19.93M | -57.8M | -128.7M | -163.62M |
純利益 | -4.26M | -30.07M | -61.66M | -97.34M | -19.93M | -57.8M | -128.72M | -163.62M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -1.607 | -1.264 | -2.29 | -3.571 | -0.729 | -2.09 | -4.515 | -6.157 |
EBIT | -2.95M | -28.75M | -66.88M | -107.43M | -23.89M | -56.78M | -115.14M | -164.41M |
EBITDA | -2.79M | -28.6M | -66.41M | -106.92M | -23.32M | -56.2M | -114.48M | -163.76M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約